期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

支气管扩张剂治疗COPD进展

下载PDF
导出
摘要 现有的治疗慢性阻塞性肺疾病（chronic obstructive pulmonary disease，COPD）的药物并不能延缓患者肺功能的逐年下降，而仅仅是减轻症状和减少并发症，其中，支气管扩张剂发挥了主要作用。目前临床常用的支气管扩张剂主要为抗胆碱能药物和β-受体激动剂。
作者 叶晓芬 蔡映云
机构地区 复旦大学附属中山医院
出处 《上海医药》 CAS 2006年第8期360-362,共3页 Shanghai Medical & Pharmaceutical Journal
关键词 支气管扩张剂 COPD 治疗 PULMONARY 慢性阻塞性肺疾病 抗胆碱能药物 DISEASE β-受体激动剂 逐年下降 临床常用
分类号 R563.9 [医药卫生—呼吸系统]
  • 相关文献

参考文献17

  • 1Vestbo J, Sorensen T, Lange P, et al. Long - term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: A randomized controlled trial [ J]. Lancet. 1999,353 (9167) : 1819.
  • 2Martin Richard J ,et al. Effect of Ipratropium Bromide Treatment on Oxygen Saturation and Sleep Quality in COPD [ J]. CHEST,1999,115(5) :1338.
  • 3Oga T, Nishimura K, et al. The effects of oxitropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease. A comparison of three different exercise tests[J]. Am J Respir Grit Care Med,2000,161 (6) :1897.
  • 4陈华良,顾宇彤,蔡映云.一种新型吸入型胆碱能受体拮抗剂──替沃托品[J].中国临床药学杂志,2001,10(5):335-336. 被引量：1
  • 5Barnes P J. The pharmacological properties of tiotropium [ J ].Chest,2000,117 (2 Suppl) : 63S.
  • 6Disse B, Antimuscarinic treatment for lung diseases from research to clinical practice[ J]. Life Sci ,2001,27:2557.
  • 7Hvizdos KM, Goa KL. Tiotropium bromide [ J ]. Drugs, 2002,62(8) :1195.
  • 8Vincken W, Van Noord JA, Greefhorst AP, et al. Improved health outcomes in patients with COPD during 1 yr' s treatment with tiotropium [ J ]. Eur Respir J,2002,19 (2) :209.
  • 9Casaburi R, Mahler DA ,Jones PW ,et al. A long - term evaluation of once - daily inhaled fiotropium in chronic obstructive pulmonary disease[J]. Eur Respir J,2002,19(2) :217.
  • 10Oga T, Nishimura K, Tsukino M, et al. A Comparison of the Effects of Salbutamol and Ipratropium Bromide on Exercise Endurance in Patients With COPD[ J]. Chest,2003,123 (6) : 1810.

二级参考文献14

  • 1[1]D'Alonzo GE, Smolensky MH, Feldman S, et al.Bambuterolin the treatment of asthma[J]. Chest, 1995, 107(2) :406.
  • 2[2]Rosenborg J, Larsson P, Nyberg L. Pharmacokinetics ofbambuterol during oral administration of plain tablets andsolution to healthy adults[J]. Br J Chin Pharmacol, 2000, 49(2) :199.
  • 3[3]Handley DA, Scnanayake CH, Dutczak W, et al. Biologicalactions of formoterol isomers [ J ]. Pulm Pharmacol Ther,2002, 15(2): 135.
  • 4[4]Ltvall J. The long and short ofβ2- agonists [ J]. PulmPharmacol Ther, 2002, 15(6) :497.
  • 5[5]Settipane RA. Defining the effects of an inhaled eorticosteroidand long - acting beta - agonist on therapeutic targets [ J ].Allergy Asthma Proc, 2003,24(2) :85.
  • 6[6]Barnes PJ. Scientific rationale for inhaled combination therapywith long- acting beta2- agonists and cortieosteroids [ J]. EurRespir J, 2002,19(1) :182.
  • 7Van Noord JA. Bantjo TH. Eland ME. et al.A randomizedcontrolled comparision of tiotropium and ipratropium in thetreatment of chronic obstructive pulmonary disease[].Thorax.2000
  • 8Disse B. Rominger K. Serby CW. et al.The pharmacokinetic(PK) profile of tiotropium during long-term treatmen0 in Sta-ble COPD[].American Journal of Respiratory and Critical Care Medicine.1999
  • 9Barnes PJ,Belvis MG,Mak JC.Tiotropium bromide (Ba 679BR).a novel long acting muscarimic antagonist for the treat-ment of obstructive airways disease[].Life Sciences.1995
  • 10Maesen FPV,Smeets JJ,Sledsenes TJH. et al.Titropium bro-mide, a new long-acting antimuscarinic bronchodilator a pharm-codycamic study in patients with chronic obstructive Pulmonarydisease[].European Respiratory Journal.1995

共引文献3

上海医药
2006年 第8期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部